Everolimus is another well-researched derivative from rapamycin, including advanced RCC, HR-positive/HER2-negative mammary neoplasms, pancreatic neuroendocrine tumors, and ependy malignant cell astrocytoma [215]. Here, ERBB2 is linked to breast cancer.